EUGIA PHARMA FDA Approval ANDA 216342

ANDA 216342

EUGIA PHARMA

FDA Drug Application

Application #216342

Application Sponsors

ANDA 216342EUGIA PHARMA

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORALEQ 25MG BASE0ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
002TABLET;ORALEQ 100MG BASE0ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
003TABLET;ORALEQ 150MG BASE0ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-06-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

EUGIA PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216342
            [companyName] => EUGIA PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 25MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 100MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERLOTINIB HYDROCHLORIDE","activeIngredients":"ERLOTINIB HYDROCHLORIDE","strength":"EQ 150MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/22\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-22
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.